Rankings
▼
Calendar
ORGO Q1 2016 Earnings — Organogenesis Holdings Inc. Revenue & Financial Results | Market Cap Arena
ORGO
Organogenesis Holdings Inc.
$338M
Q1 2016 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$15,550
Operating Income
-$15,550
Net Income
-$15,550
EPS (Diluted)
$-0.00
Cash Flow
Operating Cash Flow
-$241
Free Cash Flow
-$241
Stock-Based Comp.
$0
← FY 2016
All Quarters
Q2 2016 →
